Prolonged antiviral therapy with peginterferon to prevent complications of advanced liver disease associated with hepatitis C: Results of the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

被引：0
|
作者：
Di Bisceglie, Adrian M.
Shiffman, Mitchell L.
Everson, Gregory T.
Lindsay, Karen L.
Everhart, James E.
Wright, Elizabeth C.
Lee, William M.
Lok, Anna S.
Bonkovsky, Herbert
Morgan, Timothy R.
Dienstag, Jules L.
Ghany, Marc
Morishima, Chihiro
Snow, Kristin K.
机构：
[1] St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO 63103 USA
[2] Virginia Commonwealth Univ, Med Ctr, Hepatol Sect, Richmond, VA USA
[3] Univ Colorado, Sch Med, Div Gastroenterol & Hepatol, Sect Hepatol, Denver, CO 80202 USA
[4] Univ So Calif, Keck Sch Med, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA
[5] NIDDKD, Div Digest Dis & Nutr, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[6] NIDDKD, Off Director, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[7] Univ Texas, SW Med Ctr, Div Digest & Liver Dis, Dallas, TX 75230 USA
[8] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA
[9] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA
[10] Univ Connecticut, Ctr Hlth, Dept Mol & Struct Biol, Farmington, CT USA
[11] Univ Connecticut, Ctr Hlth, Liver Biliary Pancreat Ctr, Farmington, CT USA
[12] Univ Calif Irvine, Div Gastroenterol, Irvine, CA USA
[13] Univ Calif Irvine, Gastroenterol Serv, Irvine, CA USA
[14] VA Long Beach Healthcare Syst, Irvine, CA USA
[15] Massachusetts Gen Hosp, Gastrointestinal Unit, Med Serv, Boston, MA 02114 USA
[16] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[17] Harvard Univ, Sch Med, Boston, MA 02115 USA
[18] NIDDKD, Liver Dis Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD USA
[19] Univ Washington, Dept Lab Med, Div Virol, Seattle, WA 98195 USA
[20] New England Res Inst, Watertown, MA 02172 USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LB1
引用
收藏
页码：290A / 290A
页数：1
相关论文
共 50 条
  • [1] Design of the halt-c trial (hepatitis C antiviral long-term treatment to prevent cirrhosis).
    Di Bisceglie, AM
    Bonkovsky, HL
    Dienstag, JL
    Everson, GT
    Lindsay, KL
    Gretch, DR
    Hoefs, JC
    Lee, WH
    Lok, AS
    Tralka, TS
    Shiffman, ML
    Wright, EC
    GASTROENTEROLOGY, 2000, 118 (04) : A1435 - A1435
  • [2] Evolution of Hepatic Steatosis in Patients with Advanced Hepatitis C: Results from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
    Lok, Anna S.
    Everhart, James E.
    Chung, Raymond T.
    Kim, Hae-Young
    Everson, Gregory T.
    Hoefs, John C.
    Greenson, Joel K.
    Sterling, Richard K.
    Lindsay, Karen L.
    Lee, William M.
    Di Bisceglie, Adrian M.
    Bonkovsky, Herbert L.
    Ghany, Marc G.
    Morishima, Chihiro
    HEPATOLOGY, 2009, 49 (06) : 1828 - 1837
  • [3] CHANGES IN HEALTH-RELATED QUALITY OF LIFE ARE ASSOCIATED WITH DISEASE PROGRESSION AND PEGINTERFERON THERAPY IN PATIENTS WITH ADVANCED HEPATITIS C IN THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL
    Snow, Kristin K.
    Bonkovsky, Herbert L.
    Fontana, Robert J.
    Hoofnogle, Jay H.
    Kim, Hae-Young
    HEPATOLOGY, 2008, 48 (04) : 428A - 429A
  • [4] Herbal product use by persons enrolled in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
    Seeff, Leonard B.
    Curto, Teresa M.
    Szabo, Gyongyi
    Everson, Gregory T.
    Bonkovsky, Herbert L.
    Dienstag, Jules L.
    Shifftnan, Mitchell L.
    Lindsay, Karen L.
    Lok, Anna S. F.
    Di Bisceglie, Adrian M.
    Lee, William M.
    Ghany, Marc G.
    HEPATOLOGY, 2008, 47 (02) : 605 - 612
  • [5] COFFEE INTAKE IS ASSOCIATED WITH LOWER RATES OF LIVER DISEASE PROGRESSION IN CHRONIC HEPATITIS C: FINDINGS FROM THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL
    Freedman, Neal D.
    Everhart, James E.
    Lindsay, Karen
    Ghany, Marc G.
    Curto, Teresa M.
    Abnet, Christian C.
    Sinha, Roshmi
    HEPATOLOGY, 2008, 48 (04) : 1101A - 1102A
  • [6] HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial
    Morishima, Chihiro
    Morgan, Timothy R.
    Everhart, James E.
    Wright, Elizabeth C.
    Shiffman, Mitchell L.
    Everson, Gregory T.
    Lindsay, Karen L.
    Lok, Anna S. F.
    Bonkovsky, Herbert L.
    Di Bisceglie, Adrian M.
    Lee, William M.
    Dienstag, Jules L.
    Ghany, Marc G.
    Gretch, David R.
    HEPATOLOGY, 2006, 44 (02) : 360 - 367
  • [7] Clinical model to predict cirrhosis in patients in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
    Lok, AS
    Everhart, JE
    Everson, G
    Wright, EC
    Sterling, R
    Ghany, M
    Goodman, Z
    HEPATOLOGY, 2002, 36 (04) : 315A - 315A
  • [8] Retreatment of HCV non-responders with peginterferon and ribavirin: Results from the lead-in phase of the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) Trial
    Shiffman, M
    HEPATOLOGY, 2002, 36 (04) : 295A - 295A
  • [9] Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
    Simon, Tracey G.
    King, Lindsay Y.
    Zheng, Hui
    Chung, Raymond T.
    GASTROENTEROLOGY, 2014, 146 (05) : S966 - S966
  • [10] HEPATIC STEATOSIS DECREASES WITH ADVANCING HEPATIC FIBROSIS: FINDINGS FROM THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS TRIAL (HALT-C)
    Lok, Anna S. F.
    Everhart, James E.
    Chung, Raymond T.
    Kim, Hae-Young
    Everson, Gregory T.
    Hoefs, John C.
    Greenson, Joel K. K.
    HEPATOLOGY, 2008, 48 (04) : 1101A - 1101A
12345